April 2012 - Page 7 of 18

FridayApr 20, 2012 11:36 am

Advance Cell Technology, Inc. (ACTC) Completes Treatment of Third Dry AMD Patient in Phase I/II Clinical Trial

Advanced Cell Technology, a biotech company focused on the field of regenerative medicine, today reported the successful completion of the dosing of the third patient in its phase I/II trial for dry age-related macular degeneration (AMD) using retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs). The company has already conducted the procedure in six other patients at UCLA, and said it anticipates adding more sites in the near future. Gary Rabin, chairman and CEO of ACT, also noted the prestige of individuals participating in the trials. "The completion of enrollment of the first cohort of patients in…

FridayApr 20, 2012 8:36 am

SmallCapVoice Featured Company: PositiveID Corp. (PSID)

PositiveID is an emerging growth company focused on the development of cutting-edge technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for the U.S. homeland defense industry. Microfluidic Systems (MFS), the company’s wholly owned subsidiary, specializes in developing microfluidic systems for the automated preparation and performance of biologic assays – detecting biological threats at high-value locations and analyzing samples in a medical environment. PositiveID acquired MicroFluidic Systems in May 2011. MFS’ microfluidic technology assuages every existing problem by replacing robotics with integrated microfluidics, thus reducing cost and improving reliability. MFS’ microfluidic technology also automates…

FridayApr 20, 2012 8:35 am

SmallCapVoice Featured Company: Medical Marijuana, Inc. (MJNA)

Medical Marijuana is focused on becoming the cannabis and hemp industry’s foremost global innovator. The company’s aim is leveraging its team of professionals to source, evaluate, invest in, and purchase value-added sustainable companies – at the same time allowing them to retain their integrity and entrepreneurial spirit. Medical Marijuana strives to create industry awareness, honor past and present visionaries and activists, and offer a platform from which the industry can emerge as a global sustainable economy. The company recognizes the broad and unparalleled opportunities existing within the fast-growing hemp and medical marijuana industries. Scientific recognition of cannabis has placed legalized…

FridayApr 20, 2012 8:29 am

Rosetta Genomics, Ltd. (ROSG) Receives European Patent for miR-34a Use in Preparing Pharmaceuticals to Treat p53-Negative Cancers

Rosetta Genomics announced today that it has received a grant from the European Patent Office for a patent claiming the use of miR-34a for the preparation of pharmaceuticals to treat p53-negative cancers. A core element of Rosetta Genomics’ microRNA technology in the development of p53-negative-related cancer therapeutics is covered in the issued claims. The patent is owned jointly with Yeda, a technology transfer company of the Weizmann Institute of Science in Rehovot, Israel. The p53 protein, a sequence-specific transcription factor, functions as a major tumor suppressor in mammals. One of the most frequent genetic alterations in human cancer is the…

ThursdayApr 19, 2012 3:58 pm

Rockwell Diamonds, Inc. (RDIAF) Issues Update on Mining Activities and Corporate Strategy

Rockwell Diamonds reported a strategic and operational update on the company’s recent mining activities. The company owns an interest in three producing diamond mines in South Africa. Rockwell Diamonds is ramping up production at the Tirisano mine and expects this mine to be operating at full capacity by the end of July 2012. The company recently approved an equipment upgrade at Tirisano that will enable the company to deal with production problems associated with wet ores. Rockwell Diamonds reported strong growth in carat production at the Saxendrift mine, with year-over-year production rising by 50%. The company attributed the gain to…

ThursdayApr 19, 2012 2:46 pm

Location Based Technologies, Inc. (LBAS) Forms Strategic Partnership with West Coast Customs

Location Based Technologies Inc. (LBT), designer and developer of locator devices, today announced it has entered into a strategic partnership with West Coast Customs® (WCC), a luxury automotive restyling center with franchise operations worldwide. PocketFinder GPS easily attaches to any powered vehicle and allows the user to accurately locate their vehicle, and those in it, at any time and from almost anywhere in the world. Per the agreement, PocketFinder Vehicle® GPS devices will be installed into the WCC’s custom automobiles. “LBT is proud to be chosen as West Coast Customs’ preferred in-vehicle GPS solution,” Dave Morse, CEO of LBT stated…

ThursdayApr 19, 2012 12:53 pm

SmallCapVoice: Marley Coffee (JAMN) And AVT, Inc. Join Together For New Branded Automated Retailing Solutions

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced a licensing partnership agreement with AVT, Inc. (Pink Sheets:AVTC), a leading developer of automated and self-service retailing systems, to create high-end Marley Coffee branded automated coffee vending and merchandising machines for retail locations around the world. Both companies are seeking to target college campuses, traditional retail locations, high-density traffic areas, theatres, hotels and traditional foodservice vendors. Two of the AVT-developed Marley Coffee-branded vending machines will be unveiled at the National Automatic Merchandising Association (NAMA) OneShow at the Venetian/Sands in Las Vegas, April 25-27, at AVT, Inc.’s…

ThursdayApr 19, 2012 12:46 pm

SmallCapVoice: Advanced Medical Isotope Corp. (ADMD) Adds Regional Customer

Advanced Medical Isotope has finalized a sole-source contract with Kennewick General Hospital of Kennewick, Washington for the supply of short-lived radioisotopes primarily used in Positron emission tomography (PET) as well as for other medical isotopes utilized for diagnostic imaging and for therapeutic applications. Positron emission tomography (PET) has rapidly become a preferred scanning technique in medical research. A PET scanner utilizes radiation emitted from a patient to develop three dimensional images that assist in diagnosis with greater clarity than Magnetic Resonance Imaging (MRI) alone, and with computed tomography (CT) provides exceptionally detailed images for various types of cancers, cardiac disease…

ThursdayApr 19, 2012 12:42 pm

FluoroPharma Medical (FPMI) In Summary

FluoroPharma Medical, a developer of imaging agents for use with positron emission tomography (PET) scanning, helps to make visible subtle biological processes occurring deep within the body. From its founding in 2003, with technology licensed from Massachusetts General Hospital, the company has been steadily developing important imaging drugs for diagnostic testing, including much needed PET tracers for use in the diagnosis of cardiac disease at the cellular and molecular level. Below are some of the key facts relating to FluoroPharma. Lead Products: • BFPET – Myocardial perfusion imaging • CardioPET – Cardiac viability assessment • VasoPET – Inflamed atherosclerotic plaque…

ThursdayApr 19, 2012 12:26 pm

Palatin Technologies, Inc. (PTN) Announces Start of Second Phase I Trial of Its Obesity Compound

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and significant commercial potential. Obesity is also a focus of the company. Palatin Technologies reported today that a second Phase I clinical trial of AZD2820 has begun with the dosing of the first patient. The compound is administered under the skin and is a peptide melanocortin receptor partial agonist which is under development for treating obesity. The compound is a clinical candidate selected by European drug firm AstraZeneca (NYSE: AZN) from a collaborative research program with Palatin Technologies. AstraZeneca has…

Site Search

Company Search

Month: April 2012